NCT01072227 Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Taiwan Status TERMINATED Phase N/A
NCT01072214 A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01072162 Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect Status COMPLETED Phase PHASE1
NCT01072149 A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo Status COMPLETED Phase PHASE3
NCT01068925 Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01068587 MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT01067339 Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans Status COMPLETED Phase PHASE3
NCT01064947 Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT01061541 Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™ Status COMPLETED Phase PHASE2
NCT01060384 Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT01059617 Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults Status COMPLETED Phase PHASE1